We're pleased to share financial results and recent corporate achievements for the first quarter of 2024 as well as upcoming plans to share topline GSBR-1290 Phase 2a 12-week obesity data. Read the full announcement here: https://lnkd.in/eZaDDkCu
Exciting!
Exciting times!